264
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

A phase II clinical trial of fludarabine and cyclophosphamide followed by thalidomide for angioimmunoblastic T-cell lymphoma. An NCRI clinical trial. CRUK number C17050/A5320

, , , , , , , , & show all
Pages 2232-2234 | Received 11 Jul 2015, Accepted 15 Dec 2015, Published online: 22 Mar 2016
 

Acknowledgements

We gratefully acknowledge the patients who participated in this trial, the local investigators and site staff. In addition, we would like to thank the Independent Data Monitoring Committee, the Trial Steering Committee, Cancer Research UK who provided funding, Lymphoma Research Trust and the NCRI Lymphoma clinical studies group.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article at http://dx.doi.org/10.3109/10428194.2015.1133814.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.